Appointed
Martin H. Huber
Class III Director
ACTU ·
ACTUATE THERAPEUTICS, INC.
appointed Martin H. Huber, MD, to the Board.
Executive movement radar
Source-linked appointments, departures, and role changes from SEC 8-K Item 5.02 filings. Every card cites the SEC source.
Showing 51–100 of 280
Appointed
Dr. Henry Wah Shing Lam
Chief Technology Officer
ModuLink Inc.
On May 1, 2026, ModuLink Inc. (the “Company”) appointed Dr. Henry Wah Shing Lam (“Dr. Lam”), aged 31, as Chief Technology Officer (“CTO”) of the Company.
Departed
J. Ross Franklin
Vice President, Chief Financial Officer and Secretary
ATLANTIC AMERICAN CORP
On April 29, 2026, J. Ross Franklin notified Atlantic American Corporation (the “Company”) of his decision to resign as Vice President, Chief Financial Officer and Secretary of the Company, effective May 27, 2026.
Appointed
Jorge Ray
Principal Accounting Officer
Core Scientific, Inc./tx
On April 30, 2026, the Board of Directors of Core Scientific, Inc. (the “Company”) appointed Jorge Ray as the Company’s Principal Accounting Officer, effective May 7, 2026.
Role change
Michael B. Petras, Jr.
Executive Chairman
SHC ·
Sotera Health Co
Michael B. Petras, Jr. will transition from his role as CEO of the Company and Chairman of the Board and, on May 1, 2026, the Board appointed Mr. Petras to serve as Executive Chairman of the Board ("Executive Chairman"), as of the Effective Date.
Appointed
Alton Shader
Chief Executive Officer
SHC ·
Sotera Health Co
appointed Alton Shader to serve as Chief Executive Officer of the Company ("CEO") and a Class II director of the Board, effective as of May 26, 2026
Departed
Richard W. Newsom
Executive Vice President and President
COMMUNITY TRUST BANCORP INC /KY/
On May 4, 2026, Community Trust Bancorp, Inc. (the “Company”) announced the planned retirement of Executive Vice President, Richard W. Newsom, effective as of February 5, 2027.
Appointed
William Lewis McFarland II
Director
SunOpta Inc.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company
Appointed
Steven Wood Presley
Director
SunOpta Inc.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company
Departed
Leslie Starr
Director
SunOpta Inc.
Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company's board of directors
Departed
Dr. Albert Bolles
Director
SunOpta Inc.
Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company's board of directors
Departed
Diego Reynoso
Director
SunOpta Inc.
Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company's board of directors
Departed
Mahes S. Wickramasinghe
Director
SunOpta Inc.
Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company's board of directors
Appointed
Alan Humes
Director
SunOpta Inc.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company
Departed
Dean Hollis
Director
SunOpta Inc.
Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company's board of directors
Appointed
Stephane Bellemare
Director
SunOpta Inc.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company
Departed
David J. Lemmon
Director
SunOpta Inc.
Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company's board of directors
Departed
Rebecca Fisher
Director
SunOpta Inc.
Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company's board of directors
Appointed
Paul DiCicco
Executive Vice President, Chief Financial Officer and Treasurer
Madison Square Garden Sports Corp.
On April 28, 2026, the Board of Directors of Madison Square Garden Sports Corp. (the “Company”) appointed Paul DiCicco as Executive Vice President, Chief Financial Officer and Treasurer effective May 11, 2026 or such later date as may be agreed (the “Commencement Date”).
Appointed
Jean-Michel Enriquez Dahlhaus
Director
WENC-UN ·
West Enclave Merger Corp.
Effective as of April 29, 2026, the following individuals were appointed to the board of directors of the Company: Jean-Michel Enriquez Dahlhaus, and Hector Madero Rivero.
Appointed
Hector Madero Rivero
Director
WENC-UN ·
West Enclave Merger Corp.
Effective as of April 29, 2026, the following individuals were appointed to the board of directors of the Company: Jean-Michel Enriquez Dahlhaus, and Hector Madero Rivero.
Appointed
Julia Brau Donnelly
Principal Accounting Officer
PINTEREST, INC.
Effective as of May 8, 2026, the Company's Board of Directors has appointed Julia Brau Donnelly, the Company's Chief Financial Officer, as principal accounting officer.
Departed
Andrea Acosta
Chief Accounting Officer
PINTEREST, INC.
On April 30, 2026, Andrea Acosta, the Company's Chief Accounting Officer, submitted her resignation to the Company to pursue another opportunity, effective May 8, 2026.
Appointed
Paul Keel
Director
COOPER COMPANIES, INC.
approved the appointment of Paul Keel to fill the new director position, effective as of July 1, 2026
Departed
Richard Wolfson
Senior Vice President, General Counsel and Corporate Secretary
CRACKER BARREL OLD COUNTRY STORE, INC
the Board of Directors of the Company determined that Mr. Wolfson could take early retirement on May 1, 2026
Role change
Jennifer Lankford
Senior Vice President, General Counsel and Corporate Secretary
CRACKER BARREL OLD COUNTRY STORE, INC
promoted the Company’s Vice President and Deputy General Counsel, Jennifer Lankford, as the Company’s next Senior Vice President, General Counsel and Corporate Secretary effective upon Mr. Wolfson’s retirement.
Appointed
Michael H. Rogers
Chief Financial Officer and Treasurer
UNIVERSAL LOGISTICS HOLDINGS, INC.
Michael H. Rogers was appointed to serve as Chief Financial Officer and Treasurer of the Company, effective June 1, 2026.
Role change
Jan Stern Reed
Chair of the Board
AVITA Medical, Inc.
while the Board appointed Jan Stern Reed as Chair of the Board while simultaneously terminating the Lead Independent Director position
Role change
Cary Vance
President and Chief Executive Officer
AVITA Medical, Inc.
On April 29, 2026, the Board of Directors (the “Board”) of AVITA Medical, Inc (the "Company") appointed Cary Vance as President and Chief Executive Officer ("CEO"), effective April 30, 2026
Appointed
Xiaomin Chen
Chief Executive Officer, director and Chairman of the Board
Advanced Biomed Inc.
Upon the recommendation of the Nominating and Corporate Governance Committee, the Board of Directors appointed Mr. Xiaomin Chen as Chief Executive Officer, director and Chairman of the Board of the Company, effective as of April 28, 2026.
Departed
Yi Lu
Chief Executive Officer, director and Chairman of the Board
Advanced Biomed Inc.
The separation of Mr. Lu from his position as Chief Executive Officer, director and Chairman of the Board is neither a resignation by Mr. Lu nor a termination by the Company (whether for cause or without cause), but rather represents a mutual agreement between the Company and Mr. Lu to effectuate a leadership transition in connection with the Strategic Pivot.
Departed
Sheen Khoury
Executive Vice President, Worldwide Sales and Marketing
A10 Networks, Inc.
On April 27, 2026, Sheen Khoury was terminated as the Executive Vice President, Worldwide Sales and Marketing of A10 Networks, Inc., effective immediately.
Appointed
Michelle Burke
Co-Chief Executive Officer
Coeptis Therapeutics Holdings, Inc.
On April 27, 2026, the Board appointed each of the following individuals to serve in the office set forth opposite his or her name, in each case to hold office at the pleasure of the Board (subject to the terms of any applicable employment or service agreement): • David Halabu — Co-Chief Executive Officer (principal executive officer); • Michelle Burke — Co-Chief Executive Officer (principal executive officer); • Brian Cogley — Chief Financial Officer (principal financial officer); and • Elissa Stall — Corporate Secretary.
Appointed
Ryan Schadel
Chief Marketing Officer
Coeptis Therapeutics Holdings, Inc.
In addition, on April 27, 2026, the Board appointed Ryan Schadel to serve as Chief Marketing Officer of the Company.
Appointed
Elissa Stall
Corporate Secretary
Coeptis Therapeutics Holdings, Inc.
On April 27, 2026, the Board appointed each of the following individuals to serve in the office set forth opposite his or her name, in each case to hold office at the pleasure of the Board (subject to the terms of any applicable employment or service agreement): • David Halabu — Co-Chief Executive Officer (principal executive officer); • Michelle Burke — Co-Chief Executive Officer (principal executive officer); • Brian Cogley — Chief Financial Officer (principal financial officer); and • Elissa Stall — Corporate Secretary.
Appointed
Brian Cogley
Chief Financial Officer
Coeptis Therapeutics Holdings, Inc.
On April 27, 2026, the Board appointed each of the following individuals to serve in the office set forth opposite his or her name, in each case to hold office at the pleasure of the Board (subject to the terms of any applicable employment or service agreement): • David Halabu — Co-Chief Executive Officer (principal executive officer); • Michelle Burke — Co-Chief Executive Officer (principal executive officer); • Brian Cogley — Chief Financial Officer (principal financial officer); and • Elissa Stall — Corporate Secretary.
Appointed
David Halabu
Co-Chief Executive Officer
Coeptis Therapeutics Holdings, Inc.
On April 27, 2026, the Board appointed each of the following individuals to serve in the office set forth opposite his or her name, in each case to hold office at the pleasure of the Board (subject to the terms of any applicable employment or service agreement): • David Halabu — Co-Chief Executive Officer (principal executive officer); • Michelle Burke — Co-Chief Executive Officer (principal executive officer); • Brian Cogley — Chief Financial Officer (principal financial officer); and • Elissa Stall — Corporate Secretary.
Departed
Eben Tessari
Chief Strategy Officer
Kiniksa Pharmaceuticals International, plc
On April 30, 2026, Eben Tessari informed Kiniksa Pharmaceuticals International, plc (the “Company”) of his decision to resign as Chief Strategy Officer of the Company to pursue another executive position within the life sciences industry.
Departed
(interim)
Christopher Meyer
Interim Chief Financial Officer
RED ROBIN GOURMET BURGERS INC
Christopher Meyer’s service as the Company’s interim principal financial officer and principal accounting officer will conclude on May 31, 2026
Appointed
Mark Graff
Chief Financial Officer
RED ROBIN GOURMET BURGERS INC
On April 29, 2026, Red Robin Gourmet Burgers, Inc. (the “Company”) appointed Mark Graff to the position of Chief Financial Officer, effective May 4, 2026.
Role change
David Ramsay
Advisor
HALO ·
HALOZYME THERAPEUTICS, INC.
Effective as of June 8, 2026, David Ramsay, the Company’s current Interim CFO, will assume an advisory role with the Company to assist during a brief transition period.
Appointed
Darren Snellgrove
Chief Financial Officer
HALO ·
HALOZYME THERAPEUTICS, INC.
Halozyme Therapeutics, Inc. (the “Company”) announced that Darren Snellgrove has been appointed to serve as the Company’s Chief Financial Officer (“CFO”), effective June 8, 2026.
Appointed
Kyle K. Brengel
Chief Operating Officer
ACRES Commercial Realty Corp.
On April 29, 2026, the Board, upon recommendation from the Compensation Committee of the Board (the “ Compensation Committee ”), appointed Andrew Fentress as the Company’s Managing Director – Capital Markets, Martin Reasoner as the Company’s Managing Director – Originations, and Kyle K. Brengel as the Company’s Chief Operating Officer, each effective at Closing and upon execution of their respective Employment Agreements (as further discussed below).
Appointed
Andrew Fentress
Managing Director – Capital Markets
ACRES Commercial Realty Corp.
On April 29, 2026, the Board, upon recommendation from the Compensation Committee of the Board (the “ Compensation Committee ”), appointed Andrew Fentress as the Company’s Managing Director – Capital Markets, Martin Reasoner as the Company’s Managing Director – Originations, and Kyle K. Brengel as the Company’s Chief Operating Officer, each effective at Closing and upon execution of their respective Employment Agreements (as further discussed below).
Appointed
Martin Reasoner
Managing Director – Originations
ACRES Commercial Realty Corp.
On April 29, 2026, the Board, upon recommendation from the Compensation Committee of the Board (the “ Compensation Committee ”), appointed Andrew Fentress as the Company’s Managing Director – Capital Markets, Martin Reasoner as the Company’s Managing Director – Originations, and Kyle K. Brengel as the Company’s Chief Operating Officer, each effective at Closing and upon execution of their respective Employment Agreements (as further discussed below).
Appointed
Laura Sepp-Lorenzino
Director
Lexeo Therapeutics, Inc.
On April 28, 2026 (the “ Appointment Date ”), Dr. Laura Sepp-Lorenzino was appointed to the board of directors (the “ Board ”) of Lexeo Therapeutics, Inc. (the “ Company ”).
Role change
Nathan Kroeker
Chief Commercial Officer
EOSE ·
Eos Energy Enterprises, Inc.
In connection with Mr. Lagi’s appointment as Chief Financial Officer, Nathan Kroeker will cease serving as the interim Chief Financial Officer of the Company and will continue to serve as the Company’s Chief Commercial Officer.
Appointed
Alessandro Lagi
Chief Financial Officer
EOSE ·
Eos Energy Enterprises, Inc.
On April 30, 2026, Eos Energy Enterprises, Inc. (“Eos” and, together with its subsidiaries, the “Company”) announced that, effective June 8, 2026, Alessandro Lagi will be the new Chief Financial Officer of the Company.
Appointed
Mark Thornton
Director
XPEL, Inc.
On April 23, 2026, the Board of Directors of XPEL, Inc. (the “Company) appointed Mark Thornton to the Board of Directors of the Company.
Departed
Shane Grant
Director
lululemon athletica inc.
Shane Grant, a member of the Board, informed the Board that he plans to retire from the Board at the end of his current term and will not stand for reelection at the Annual Meeting.
Pilot corpus: a static 200-row sample of 8-K Item 5.02 filings; not a real-time live feed. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. See methodology.